State of Texas (ibogaine policy) — A July 14 report examined Texas's decision, via Senate Bill 2308, to commit up to $50 million in grants for FDA-supervised ibogaine research, described as the largest state investment of its kind and requiring a private-sector match.
The program creates a consortium of universities, hospitals and drug developers to run trials targeting PTSD and addiction. The funding is a potential catalyst for ibogaine-focused developers seeking clinical partners and non-dilutive capital.
Source: americanhomefront.wunc.org
For the rest of that week's sector news, read our week in review.